REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 11,100
+40 (0.36%)
Last updated: Apr 24, 2026, 3:00 PM KST
REYON Pharmaceutical Revenue
In the year 2025, REYON Pharmaceutical had annual revenue of 145.93B KRW, down -1.60%. REYON Pharmaceutical had revenue of 33.90B in the quarter ending December 31, 2025, a decrease of -9.15%.
Revenue
145.93B
Revenue Growth
-1.60%
P/S Ratio
1.39
Revenue / Employee
331.66M
Employees
448
Market Cap
202.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 145.93B | -2.37B | -1.60% |
| Dec 31, 2024 | 148.30B | -2.77B | -1.83% |
| Dec 31, 2023 | 151.07B | -2.97B | -1.93% |
| Dec 31, 2022 | 154.04B | 11.24B | 7.87% |
| Dec 31, 2021 | 142.80B | 12.77B | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suheung | 722.31B |
| Daewon Pharmaceutical | 605.43B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |
| Samil Pharmaceutical Co.,Ltd | 210.25B |